Unichem Laboratories Limited

Pravin Kumar Maurya

Dhananjay Govind Sathe

Srikant V Pimple

Milind Vinayak Sathe, Sr

Bijay Kumar Padhi

Dhananjay Pramod Tattu

The present disclosure relates to a stable, reproducible and bioequivalent apixaban compositions, wherein the composition comprising apixaban having a Dparticle size of more than 100 microns, preferably between 300 and 1000 microns, and more preferably between 350 and 800 microns, and further comprising one or more pharmaceutically acceptable excipients. The present disclosure further provides a process for preparation of a pharmaceutical composition comprising apixaban by wet granulation.

Pharmaceutical composition of apixaban

A pharmaceutical composition containing cinacalcet or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients. A pharmaceutical composition containing cinacalcet or pharmaceutically acceptable salts thereof having a particle size distribution Dequal to or less than 20 &#x3bc;m, Dequal to or less than 10 &#x3bc;m, and Dequal to or less than 5 &#x3bc;m and one or more and binders in an amount of 0.9% w/w or less, relative to the total weight of composition, where the composition is not free of binder and that the total amount of binder does not exceed 0.9% w/w relative to the total weight of the composition.

Pharmaceutical compositions comprising cinacalcet hydrochloride and one or more binders

The invention relates to vortioxetine hydrobromide having particle size distribution of D98 100-200&#x3bc;, D50 35-90&#x3bc; and D5 7-30&#x3bc; as well as to a stable, reproducible and bioequivalent pharmaceutical composition comprising vortioxetine hydrobromide having particle size distribution of D98 100-200&#x3bc;, D50 35-90&#x3bc; and D5 7-30&#x3bc; and one or more pharmaceutically acceptable excipient. It is produced by wet granulation techniques.

Growing community of inventors

Pune, India

Pravin Kumar Maurya